These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 11507067)
1. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model. Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067 [TBL] [Abstract][Full Text] [Related]
2. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer. Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Ojima T; Yamaue H Surgery; 2003 Mar; 133(3):309-17. PubMed ID: 12660644 [TBL] [Abstract][Full Text] [Related]
3. In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma. Lan KH; Kanai F; Shiratori Y; Ohashi M; Tanaka T; Okudaira T; Yoshida Y; Hamada H; Omata M Cancer Res; 1997 Oct; 57(19):4279-84. PubMed ID: 9331089 [TBL] [Abstract][Full Text] [Related]
4. Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase gene. Ueno M; Koyama F; Yamada Y; Fujimoto H; Takayama T; Kamada K; Naito A; Hirao S; Mukogawa T; Hamada H; Nakajima Y Anticancer Res; 2001; 21(4A):2601-8. PubMed ID: 11724328 [TBL] [Abstract][Full Text] [Related]
5. Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter. Cao G; Kuriyama S; Gao J; Kikukawa M; Cui L; Nakatani T; Zhang X; Tsujinoue H; Pan X; Fukui H; Qi Z Gene Ther; 1999 Jan; 6(1):83-90. PubMed ID: 10341879 [TBL] [Abstract][Full Text] [Related]
6. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer. Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403 [TBL] [Abstract][Full Text] [Related]
7. [Experimental study on human pancreatic carcinoma treated by cytosine deaminase gene therapy]. Zhang S; Yuan S Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):249-51. PubMed ID: 11798763 [TBL] [Abstract][Full Text] [Related]
8. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094 [TBL] [Abstract][Full Text] [Related]
9. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas. Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532 [TBL] [Abstract][Full Text] [Related]
10. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor. Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281 [TBL] [Abstract][Full Text] [Related]
11. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice. Gnant MF; Puhlmann M; Alexander HR; Bartlett DL Cancer Res; 1999 Jul; 59(14):3396-403. PubMed ID: 10416601 [TBL] [Abstract][Full Text] [Related]
12. Enhanced selective gene expression by adenovirus vector using Cre/loxP regulation system for human carcinoembryonic antigen-producing carcinoma. Ueda K; Iwahashi M; Nakamori M; Nakamura M; Yamaue H; Tanimura H Oncology; 2000 Sep; 59(3):255-65. PubMed ID: 11053994 [TBL] [Abstract][Full Text] [Related]
13. Adenoviral oncolytic suicide gene therapy for a peritoneal dissemination model of gastric cancer in mice. Imamura Y; Ishikawa S; Sato N; Karashima R; Hirashima K; Hiyoshi Y; Nagai Y; Koga Y; Hayashi N; Watanabe M; Yamada G; Baba H Ann Surg Oncol; 2010 Feb; 17(2):643-52. PubMed ID: 20012217 [TBL] [Abstract][Full Text] [Related]
14. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine. Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy. Xie Y; Gilbert JD; Kim JH; Freytag SO Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the human carcinoembryonic antigen promoter core region in colorectal carcinoma-selective cytosine deaminase gene therapy. Cao G; Kuriyama S; Cui L; Nagao S; Pan X; Toyokawa Y; Zhang X; Nishiwaki I; Qi Z Cancer Gene Ther; 1999; 6(6):572-80. PubMed ID: 10608354 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach. Anderson LM; Krotz S; Weitzman SA; Thimmapaya B Cancer Gene Ther; 2000 Jun; 7(6):845-52. PubMed ID: 10880014 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of repeated direct intratumoral gene transfer using hemagglutinating virus of Japan-liposome method for cytosine deaminase suicide gene therapy. Kanyama H; Tomita N; Yamano T; Aihara T; Miyoshi Y; Ohue M; Sekimoto M; Sakita I; Tamaki Y; Kaneda Y; Senter PD; Monden M Cancer Res; 2001 Jan; 61(1):14-8. PubMed ID: 11196152 [TBL] [Abstract][Full Text] [Related]
19. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines. Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068 [TBL] [Abstract][Full Text] [Related]
20. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration. Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]